In SummaryThe final vote against the recommendation was 16 to 2.
The Food and Drug Administration’s federal panel stated they don’t approve of a third booster shot of Pfizer and BioNTech’s COVID-19 vaccine for people who are 16 years old and over, according to The Hill. The vote against the recommendation wasn’t even close, as it was 16 to 2.
“I don’t think a booster dose is going to significantly contribute to controlling the pandemic,” Dr. Cody Meissner of Tufts University said on CNN. “It is very important that the main message that we still transmit is that we have got to get everyone two doses.”
This news comes at a time when President Joe Biden had a strategy to give out the booster doses starting on Sept. 20. However, the FDA unanimously approved of giving Pfizer and BioNTech’s booster shot to those 65 years old and over, according to the Associated Press.
This is important news because older people tend to have compromised immune systems. According to the US Coronavirus vaccine tracker, over 180 million people in America have been fully vaccinated.
Recently, the Centers for Disease Control and Prevention (CDC) did a study and found that those who haven’t been vaccinated were 11 times more likely to die than fully vaccinated people.
“As we have shown study after study, vaccination works,” said CDC Director Rochelle Walensky on The Hill. “CDC will continue to do all we can do to increase vaccination rates across the country by working with local communities and trusted messengers and providing vaccine confidence consults to make sure that people have the information they need to make an informed decision.”